Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma

Background: Proton beam has an excellent depth dose distribution due to its unique physical properties, and thus proton beam therapy (PBT) has been tried and showed promising outcomes in hepatocellular carcinoma (HCC). The purpose of this phase II study is to evaluate the efficacy of hypofractionate...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Tae Hyun, Park, Joong-Won, Kim, Bo Hyun, Oh, Eun Sang, Youn, Sang Hee, Moon, Sung Ho, Kim, Sang Soo, Woo, Sang Myung, Koh, Young-Hwan, Lee, Woo Jin, Kim, Dae Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198869/
https://www.ncbi.nlm.nih.gov/pubmed/32411594
http://dx.doi.org/10.3389/fonc.2020.00542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198869/
https://www.ncbi.nlm.nih.gov/pubmed/32411594
http://dx.doi.org/10.3389/fonc.2020.00542

Ejemplares similares